TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
RCKT

Rocket Pharmaceuticals Inc

Healthcare · Biotechnology

3.40$ +0.0% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RCKT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
65.5% 99.2% 99.0% 99.3% 83.2% 82.7% 82.5% 78.9% 66.0% 66.8% 71.7% 58.3%
65.5% 70.6% 23.0% 77.3% 44.3% 49.8% 50.3% 46.8% 25.5% 9.9% 31.0% 23.5%
65.5% 98.2% 97.6% 98.3% 81.9% 81.7% 81.7% 78.2% 64.6% 65.9% 70.6% 57.2%
0.0% 0.0% 0.0%
0.7% 0.9% 0.6% 0.8% 7.9% 3.3% 14.6% 14.1%
0.0% 0.0% 0.0% 12.3% 8.3% 5.2% 6.2% 7.1% 6.9% 7.4% 11.8%
0.0% 0.0% 0.0% 0.1% 4.7% 4.4% 4.8% 7.6%
1,034.0% 4.0% 43.6% 53.1% 22.8% 17.4% 14.8% 8.5% 11.3% 13.0% 12.2% 16.1%
67.1% 3.7% 5.6% 4.0% 6.1% 4.9% 5.5% 4.5% 7.1% 8.6% 7.7% 9.1%
92.1% 0.0% 0.0% 0.3% 1.2% 0.5% 0.5% 0.5% 0.5% 0.9%
20.8% 1.4% 1.2% 0.4% 0.0% 0.0% 0.0% 0.0% 6.6% 0.0% 0.3%
46.2% 0.0% 37.8% 48.7% 16.5% 12.1% 5.9%
-934.0% 96.0% 56.4% 46.9% 77.2% 82.6% 85.2% 91.5% 88.7% 87.0% 87.8% 83.9%
-2,319.6% -173.0% -184.3% -263.7% -42.1% -49.2% -54.6% -99.0% -129.4% -169.4% -230.8% -436.1%
38.1% 5.8% 5.2% 6.6% 15.7% 13.2% 9.4% 12.7% 12.4% 14.8% 18.0% 33.6%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?